Company Filing History:
1 out of 20 
1 out of 1 Years Active: 2021
Title: **Shigeo Fukuyama: Innovator in Hard Tissue Bonding**
Introduction
Shigeo Fukuyama, based in Yokohama, Japan, is a distinguished inventor known for his contributions to medical adhesives. His innovative work focuses on hard tissue bonding, a critical area in the field of medicine and surgery. With a single patent to his name, Fukuyama has made significant strides that enhance biocompatibility and efficacy in medical procedures.
Latest Patents
Fukuyama holds a patent for an adhesive for hard tissue bonding, which includes an adhesive kit and bone cement. This adhesive is designed with a sufficient pot life and excellent biocompatibility, allowing it to be gradually replaced by bone over time. The patented adhesive consists of a cyanoacrylate monomer combined with beta-tricalcium phosphate or hydroxyapatite. Furthermore, the adhesive kit contains a liquid agent with the cyanoacrylate monomer and a powdery agent made up of beta-tricalcium phosphate or hydroxyapatite. The bone cement, which also includes a cyanoacrylate polymer, provides excellent compatibility while ensuring effective integration with biological tissues.
Career Highlights
Fukuyama has worked with notable institutions that include the Chiba Institute of Technology and Fukuyamaika Corporation. His dedication to research and development has positioned him as a key figure in the innovation of medical adhesives.
Collaborations
Throughout his career, Fukuyama has collaborated with talented professionals, including Kazuaki Hashimoto and Hirobumi Shibata. These partnerships have played a vital role in furthering research and enhancing the application of his patented technologies in the medical field.
Conclusion
Shigeo Fukuyama stands out as an innovative inventor whose work in adhesive technologies has the potential to significantly impact medical practices. His commitment to creating biocompatible materials showcases the importance of ongoing research in the field of medical innovations, paving the way for advancements that benefit both patients and healthcare providers.